Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+6.3%1-day move

₹648.00

prior close

₹652.50

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.0-0.0+0.0+6.3+4.7+6.5+7.1+8.8+8.0+10.3+20.4-6.2+8.0

Up moveDown movePending

AI summary

Aarti Pharmalabs submitted a compliance certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirming proper handling of securities dematerialisation for the quarter ending March 31, 2026. The RTA verified that all securities received for dematerialisation were confirmed or rejected and processed within prescribed timelines. The certificate notes that no shareholder requests for dematerialisation or rematerialisation were received during the quarter. This is a mandatory quarterly compliance filing under SEBI regulations.

Likely market impact

Routine regulatory compliance with no direct impact on operations or stock price. Indicates proper back-office functioning for securities processing.